Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 6/20 | 0.43 |
| ▸ | CCR2 | P41597 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | IP6K1 | Q92551 | 7/20 | 0.37 |
| ▸ | IP6K3 | Q96PC2 | 1/20 | 0.37 |
| ▸ | IP6K2 | Q9UHH9 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.36 |
| ▸ | RAF1 | P04049 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20073880 | 0.89 | MAPK14 (0.40) | MAPK14CCR2KCNH2IP6K1BRD4 | |
| SCHEMBL24609136 | 0.89 | MAPK14 (0.40) | MAPK14CCR2KCNH2IP6K1BRD4 | |
| SCHEMBL23778447 | 0.88 | NQO2 (0.41) | MAPK14IP6K1 | |
| SCHEMBL21082744 | 0.83 | CCR2 (0.40) | MAPK14CCR2KCNH2IP6K1 | |
| SCHEMBL23778313 | 0.82 | MAPK14 (0.46) | MAPK14CYP1A2CYP2C19RAF1CYP2C9 | |
| SCHEMBL20073881 | 0.82 | MAPK14 (0.46) | MAPK14CCR2KCNH2CYP1A2CYP2C19 | |
| SCHEMBL29709316 | 0.82 | MAPK14 (0.46) | MAPK14CCR2KCNH2CYP1A2CYP2C19 | |
| SCHEMBL23798012 | 0.81 | MAPK14 (0.45) | MAPK14CYP1A2CYP2C19RAF1CYP2C9 | |
| SCHEMBL23778317 | 0.80 | MAPK14 (0.40) | MAPK14CCR2KCNH2CHRM1 | |
| SCHEMBL23778227 | 0.80 | CCR5 (0.38) | MAPK14KCNH2IP6K1IP6K3IP6K2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3526207-B1 | HETEROCYCLIC COMPOUNDS HAVING ACTIVITY AS MODULATORS OF MUSCARINIC M1 AND/OR M4 RECEPTORS IN THE TREATMENT OF CNS DISEASES AND PAINS. | HEPTARES THERAPEUTICS LTD (GB) | 2021-09-08 | — | — | EP | disclosed |